⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABOS News
Acumen Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
ABOS
Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
globenewswire.com
ABOS
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
globenewswire.com
ABOS
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
globenewswire.com
ABOS